Chart Patterns and Trends

[Robertscott]

$EMED With over a million frequencies to choose from, WellnessPro Plus® offers the widest frequency range on the market allowing it to have numerous applications. FDA CLEARED, it features a “future-ready” modular design, making it widely adaptable to new accessories and therapies.

[Robertscott]

$EMED University research centers, doctors, and physicians around the world have overseen treatments using electrotherapy with outstanding results in the reduction of pain for a wide range of acute and chronic conditions. The WellnessPro Plus is an effective complementary treatment modality for pain relief.

[Robertscott]

$EMED Preliminary revenue for the twelve months ended Dec 31 was approximately $1.15 million, which represents a total increase in sales of 26.7% on a year-over-year basis.

[Robertscott]

$EMED Electrotherapy seems to be one of the most promising substitute to toxic and addictive painkillers. Since introducing the WellnessPro+ in 2007, ElectroMedical Technologies has been an innovation pioneer at the forefront of the alternative pain relief movement.

[BCNstocks]

$EPAZ ~ CapitalGainsReport: Monday's Bounce List: EPAZ, HMBL, INND, AABB

Epazz Inc. (OTC: EPAZ), a leading provider of drone technology, blockchain mobile apps, and cloud-based business software solutions, Let's focus mainly on their drone technology, as that is where the company seems to be focused.

ZenaDrone Inc., an EPAZ spinoff, is focused on advancing its unmanned aerial vehicle technology by incorporating machine learning software and artificial intelligence. Originally focused on revolutionizing the hemp farming sector, the company's intelligent multifunctional drones have since expanded into industrial surveillance, inspection, and monitoring solutions and are now heavily focused on military applications, a major driver for potential revenue.

The ZenaDrone team will be utilizing predictive AI analytics, a method that employs various techniques such as machine learning algorithms, statistical modeling, and data mining to create predictive models and forecast future outcomes based on acquired data. These techniques allow for sophisticated predictive modeling and enable the drones to provide real-time data for a wide range of applications

Just last week, EPAZ announced an expansion of its ZenaDrone facilities in Dubai, UAE. The move is aimed at increasing the production of its flagship product, the ZenaDrone 1000, to fulfill obligations under several pilot program agreements.

These agreements allow customers to use the ZenaDrone 1000 for an extended period, and the company has several scheduled demonstrations of the drone in multiple countries. ZenaDrone aims to produce over 20 drones per month, with the capacity to produce 40 in the same facility, compared to the 10 produced in 2022.

Over the last few months, ZenaDrone has been showcasing its ZenaDrone 1000 in front of the US military, gaining traction from both the US Air Force and Army. The upcoming test will be the first time the drone is used in a military environment, and will allow ZenaDrone to move to Technology Readiness Level 7 (TRL). ZenaDrone is now qualified to submit a Phase II SBIR grant for up to $1.2 million in external funding, which will be their second direct-to-Phase II project.

Recently, Zenadrone also received a letter of support from the US Air Force to use the ZenaDrone 1000 for drone cargo delivery, including blood transport, and will be working with a team from an overseas base to test the drone platform under battlefield conditions.

With growing interest from the US military and qualification to submit a Phase II SBIR grant for external funding of its cargo delivery solution, ZenaDrone's future looks bright. The company is also working on civilian use cases with great success in the security and agriculture fields. Keep EPAZ on your watchlist for future updates.

https://www.marketscreener.com/quote/stock/EPAZZ-INC-111313555/news/CapitalGainsReport-Monday-s-Bounce-List-EPAZ-HMBL-INND-AABB-43518492/

[Robertscott]

$EMED As the Company moves closer to production of the new next-generation flagship device, management plans to offer a special upgrade and exchange program to existing clients, which will be bundled with a lifetime warranty.

[Robertscott]

$EMED Management notes that 2023 will see the launch of the WellnessPro Infinity™, continued expansion in its sales team, a strong focus on value-add strategic partnerships, research partnerships and further customer affordability strategies as the Company monetizes its market-leading next-generation drug-free pain therapy technology.

[Robertscott]

$EMED Bio-electrical stimulation is a safe non toxic pain management therapy that activates the body’s innate
ability to heal itself. Therapy provides targeted pain alleviation to specific areas of the body by
modifying its electrical language related to pain, regulating signals and stimulating endogenous opioids
distributed in the nervous systems, particularly in circuits involved in pain modulation, reward,
responses to stress, and autonomic control.

[Robertscott]

$EMED Preliminary revenue for the twelve months ended Dec 31 was approximately $1.15 million, which represents a total increase in sales of 26.7% on a year-over-year basis.

[Robertscott]

$EMED Electricity enables information to circulate in the body, electrotherapy manipulates a specific part of the information by pulsating electrical waves interfering with the transmission of pain signals.
Our nervous system is composed of our brain and our spinal cord, which combine to form the central nervous system; and our sensory and motor nerves, which form the peripheral nervous system. Nerves send information about what is happening in our environment to the brain via the spinal cord. The brain then sends information back to our nerves, helping us to perform actions in response. By treating specific body areas and varying frequency, wavelength and intensity applied, electrotherapy devices can manipulate impulses and target actions to alleviate pain or they can disrupt pain signals.

[Robertscott]

$EMED Electrotherapy seems to be one of the most promising substitute to toxic and addictive painkillers. Since introducing the WellnessPro+ in 2007, ElectroMedical Technologies has been an innovation pioneer at the forefront of the alternative pain relief movement.

[Stockstax]

$EPAZ ~ EPAZ’s Zenadrone Seeks To Generate Revenue Off of Chinese Drone Ban in U.S.

[BCNstocks]

$APSI undervalued at .29 after hitting over .70 the end of December! The merger with Tradition Transportation Group was recently finalized and last week two corporate Tweets updates hit along with an 8K. More updates are expected soon!
https://www.sec.gov/ix?doc=/Archives/edgar/data/1553264/000168316823000673/aquapower_8k.htm

Aqua Power Systems Takes Aggressive Action to Combat Suspected Illegal “Naked” Short Selling

$APSI Corporate Announcement. https://t.co/s6k2wOMmMi

— APSI - Aqua Power Systems Inc (@inc_apsi) January 26, 2023

$APSI Corporate Announcement.
https://www.mcapmediawire.com/aqua-power-systems-takes-aggressive-action-to-combat-suspected-illegal-naked-short-selling/

[Robertscott]

$PVSP is working hard as well to build value to shareholders.

[Robertscott]

$PVSP Taken $1 million in debt off the books.

[Robertscott]

$PVSP U.S. voters in November voting on weed legalization, a poll released by Winthrop University(opens in new tab) found that 78% of adults in South Carolina, including a majority of Republicans, would like to see medical cannabis reform. An additional 54% of voters were in favor of recreational weed legalization.

[Stockstax]

$GMER recent article featuring Good Gaming Inc., plus news.
#Gaming #Roblox #Minecraft #NFT

Good Gaming Inc. Signs Development Partnership Agreement With Meraki Studios B.V. For New Minecraft And Roblox Games And Explores AI Technology Integration For Games In 2023
https://finance.yahoo.com/news/good-gaming-inc-signs-development-133000262.html

GMER in Focus as Crypto and NFT Stocks Rise from the Grave
https://www.wallstreetpr.com/gmer-in-focus-as-crypto-and-nft-stocks-rise-from-the-grave-55540

[Robertscott]

$HTSC On fire today

[Snowie]

$GMER ~ The online gaming industry has experienced incredible growth in recent years, with millions of players logging in daily to enjoy the latest games and platforms. Leading the charge are two of the biggest names in the industry: Minecraft and Roblox. $GMER #Roblox #Minecraft
https://ih.advfn.com/stock-market/USOTC/good-gaming-qb-GMER/stock-news/90164469/good-gaming-inc-to-launch-its-first-extreme-game

[Robertscott]

$HTSC Fortune owns 182 mineral claims in the Timmins mining camp in Ontario Canada.

Massive and compelling mining property that has a strong potential for multiple metallic commodities and wealth.

Robust Exploration Potential - Tier 1 Nickel Project, 100% owned, and proactive government support. Direct exposure to nickel.

A rare land position that is near rich world-class deposits.

Geophysical Airborne Survey Interpretation has identified drill-ready targets.

Scalability - Potential to develop a staged nickel and gold business with production.

Favorable mining culture and excellent infrastructure in the regions.

We believe we are at the right place at the right time. The mining claims we own have been ignored for the past 50 years. Now the EV industry is demanding nickel as a key battery metal.

[Stockstax]

$AGYP ~ Chart (RSI 45)
Recent News: Allied Energy Corp Signs Definitive Agreement with Enerhash USA LLC to Partner on Flare Gas Powered Bitcoin Mining Projects #Bitcoin
https://finance.yahoo.com/news/allied-energy-corp-signs-definitive-133000584.html

[Robertscott]

$PVSP Pervasip currently has about 5,000,000,000 shares of common stock issued and outstanding, corresponding to about 15% of Pervasip’s fully diluted issued and outstanding common stock. Pervasip additionally has 850,000 shares of Series K convertible preferred stock issued and outstanding, corresponding to 85% of Pervasip’s fully diluted issued and outstanding common stock, as well as various other convertible securities.

[Robertscott]

$PVSP's Improved Capital Structure:

Pervasip currently has about 5,000,000,000 shares of common stock issued and outstanding, corresponding to about 15% of Pervasip’s fully diluted issued and outstanding common stock. Pervasip additionally has 850,000 shares of Series K convertible preferred stock issued and outstanding, corresponding to 85% of Pervasip’s fully diluted issued and outstanding common stock, as well as various other convertible securities.

Holders of Pervasip’s issued and outstanding common shares as of the record date will receive an aggregate of 15,000,000 shares of Artizen common stock, corresponding to 15% of Artizen’s fully diluted issued and outstanding common shares upon completion of the transaction (in addition to retaining their shares in Pervasip). Likewise, holders of Pervasip’s Series K and other convertible securities will receive an aggregate of 85,000,000 shares of Artizen common stock, the vast majority of which will be subject to lock-up restrictions prohibiting sales prior to Artizen’s realization of material growth and other performance objectives. Artizen will have 100,000,000 common shares outstanding on a fully diluted basis upon completion of the transaction, with no convertible debt or other securities.

The Company is working with its auditors to complete the required financial audits, including one for Pervasip on a consolidated basis and another for Artizen on a consolidated basis (without Pervasip). Once complete, a Form 10 Registration Statement will be filed with the SEC for Artizen to initiate the spin-off process. Additional information regarding the status and timing of the transaction and the various required regulatory and other approvals will be provided as it becomes available. Pervasip has commenced evaluation of potential targets for acquisition upon completion of the Artizen spin-off.

[Robertscott]

$PVSP Overview https://www.otcmarkets.com/stock/PVSP/overview

[Robertscott]

$PVSP Pervasip common shareholders will receive 15% or 15,000,000 shares in Artizen Corp at the Record Date
The Record Date is the day end of day before the date at which the new Artizen Ticker goes life
Pervasip are not shortchanged. On an as if fully diluted basis, all Pervasip common shares amount to approximately 13.8% of all outstanding shares; we set 15% aside for all common shareholders in Artizen Corp

[Robertscott]

$PVSP While the local Washington market presents compelling opportunities for the acquisition and roll-up of wholesale flower, concentrate, and other related production assets by Zen’s independent cultivators, the regulatory environment in Washington prevents vertical integration into retail assets. That limitation is a significant constraint on growth since Zen’s independent cultivators cannot acquire dispensary assets to internalize retail revenues that are typically about three times wholesale receipts. Stated differently, Artizen could be generating about three times its current revenues, or about $46 to $52 million, if Zen’s existing footprint was in another state. Thus, diversification has been and remains a key strategic focus – both within Washington by expanding Zen’s offerings and exploiting compliant acquisition opportunities, and in valuable emerging cannabis markets by replicating Artizen’s proven formula for success in new U.S. and Canadian geographies.

https://www.barrons.com/articles/pervasip-announces-artizen-spin-off-01673965206?mod=md_stockoverview_news

[Robertscott]

$PVSP In response to hundreds of questions, we are going to provide more detail regarding the Artizen spinoff via several tweets. We will also post a pdf with all answers online by end of the day.

[Robertscott]

$PVSP holders of Pervasip’s Series K and other convertible securities will receive an aggregate of 85,000,000 shares of Artizen common stock, the vast majority of which will be subject to lock-up restrictions prohibiting sales prior to Artizen’s realization of material growth and other performance objectives.

[Robertscott]

$PVSP PERVASIP is in the process of looking for other opportunities to create value.
The current team has cleaned up the business.
Taken $1 million in debt off the books.
Built a solid finance and accounting infrastructure.
And lastly, Pervasip will have audited financials and be ready to make a run on its own for much higher value!

[Robertscott]

$PVSP Pervasip Announces Artizen Spin Off

https://finance.yahoo.com/news/pervasip-announces-artizen-spin-off-141500515.html

[Robertscott]

$NBIO News: ACCESSWIRE / January 10, 2023 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology Company pioneering the development of monoclonal antibodies targeting various cancer types, announced today the completion and closure of enrollment for the final cohort of patients involved in the Company's Phase I trial to evaluate Pritumumab ("PTB") as a treatment for Brain Cancer.

Following the completion of patient dosing in this fifth and final cohort, the Company's Phase I trial will be complete. The Company will then prepare and submit research data to the FDA in preparation for the launch of its Phase 2 clinical research.

"Closing enrollment for this final cohort of our Phase I trial is a tremendous milestone that marks the start of our preparation for Phase II research," noted Nascent CEO, Sean Carrick. "This is a significant accomplishment in the advancement of our Biologic asset and in our mission to help future patients in their battle against this terrible disease."

PTB is a natural human antibody that binds to Cell surface Vimentin (also referred to as ectodomain vimentin), a protein expressed on the surface of epithelial cancers. PTB is used as a targeted immunotherapy which seeks out only cancer cells while sparing healthy cells.

[Robertscott]

$PVSP Located in beautiful Tacoma, in between Lacey and Seattle, this 24,000 square feet Cultivation and Nursery facility has 4 flower rooms and some of the most advanced cooling and irrigation system setup in Washington.

[Robertscott]

$MASN ABOUT MAISON LUXE

Maison Luxe offers luxury retail consumer items. The Company operates as a niche high-end luxury goods retailer, helping interested consumers obtain rare luxury items that may otherwise not be reliably available due to the nature of the luxury retail marketplace. The Company focuses its efforts primarily within the fine timepiece and jewelry segments, both on a wholesale and B2C (business-to-consumer) basis. The Company also owns its Amani Jewelers subsidiary, which operates in the jewelry marketplace, with a strategic focus on the rapidly growing lab-grown diamonds market. In addition, Maison Luxe holds a significant investment position in Aether Diamonds, which was founded in 2020 as the world's first known captured carbon lab-grown diamond producer.

[Robertscott]

$PVSP DESCRIPTION
We provide business consulting and marketing services to public companies. More than 100 companies have purchased space on our website https://privateequitymarkets.us/. Our website features publicly traded companies and highlights the mining, technology, bio-tech, green-tech and cannabis industries. Services include free listings of press releases and a news feed.

[Robertscott]

$PVSP technologies in high value emerging markets, together with Zen Asset Management LLC (“ZAM”) today announced the execution of a letter of intent (“LOI”) to acquire substantially all of the assets of BCCTG LLC (“BCCTG”).
BCCTG, owner of various brands, including Emerald City Cultivation, Emerald City Cured, Dabco, Dabs4Less and Vapes4less has agreed to terms to be acquired by ZAM, combining its brands and concentrate offerings with ZAM’s Artizen brands to form a powerful portfolio of brands, covering flower, pre-roll, dabbable concentrates and vape products.

BCCTG’s brands, which generate $4 million in annualized revenues, manufactured in a state-of-the-art laboratory. The terms include acquisition of all BCCTG assets, including its brands, access to a Tier 2 producer/processor license and a turnkey laboratory which will be used to also manufacture new products under the Artizen brand.

[Robertscott]

$PVSP We also invested in a small Korea based research entity, KRTL, to establish an early foothold in the rapidly expanding world of medical fungi, with a specific focus on Psilocybin. It is an entry to a large database of related research, various research entities actively involved in related development projects and provides Pervasip with a perfect perch to look at various fungi opportunities across the globe.

[Robertscott]

$PVSP the mature markets provide relevant insights into future sales distribution across key categories with flower and pre-rolls still leading at 59%, followed by concentrates (dabs/vape) at 29% and finally edibles and beverages at a combined 9%
Artizen brands will materially expand their flower market share and enter the concentrates and edibles market with a goal of occupying top 10% market share positions in each vertical.

[Robertscott]

$PVSP ZAM provides consulting, leasing, intellectual property licensing and other long-term arrangements to cannabis operators, including management of the Artizen™ brand assets

https://www.pervasip.net/zen-asset-management-zam

[BottomBounce]

Northern Dynasty Minerals Ltd. engages in the exploration of mineral properties in the United States. Its principal mineral property is the Pebble Copper-Gold-Molybdenum-Silver-Rhenium project comprising 1,840 mineral claims that covers an area of approximately 274 square miles located in southwest Alaska, 17 miles from the villages of Iliamna and Newhalen, and approximately 200 miles southwest of the city of Anchorage. The company was formerly known as Northern Dynasty Explorations Ltd. and changed its name to Northern Dynasty Minerals Ltd. in October 1997. Northern Dynasty Minerals Ltd. was incorporated in 1983 and is headquartered in Vancouver, Canada. $NAK

[Robertscott]

$PVSP The below Washington State (WA) sales by category chart provides information on how monthly sales of approximately $100 million in retail sales breaks down by product category. It might also be informative to understand that June ’22 sales over June ’19 sales (pre pandemic) show an almost 17% increase. While WA sales are slightly above other mature cannabis states (NV, CO, OR), similar increases can be seen in those markets. An exuberant pandemic triggered belief in continued rapid growth has led to over development of production infrastructure and resulted in material oversupply of bulk cannabis flower. The market is in the process of correcting and the Company estimates Q3 2023 being the end of the corrective period, resulting in strengthening prices.

https://www.benzinga.com/pressreleases/22/09/g28756512/24-month-roadmap-to-50-million-in-sales

[Robertscott]

$PVSP Lacey, WA

The original garden that has been growing Artizen flower since 2015. This 75,000 square feet building is hosting cultivation, central warehousing for all WA gardens, and retail distribution.

[Robertscott]

$PVSP BCCTG’s brands, which generate $4 million in annualized revenues, manufactured in a state-of-the-art laboratory. The terms include acquisition of all BCCTG assets, including its brands, access to a Tier 2 producer/processor license and a turnkey laboratory which will be used to also manufacture new products under the Artizen brand.

According to the terms of the LOI, Zen will acquire the assets of BCCTG for cash, paid from contributed revenues with a monthly upper limit and cash neutral on current pre-transaction financials. In addition, Pervasip will provide a group of BCCTG owners, investors and employees 10.2% of Pervasip’s fully diluted equity in the form of restricted preferred stock.

“As outlined in our 24-months roadmap, which we published on September 6, 2022, this acquisition checks 2 of our boxes on the list of strategic objectives to be accomplished by year’s end 2022,” said German Burtscher, Pervasip’s CEO. “Not only will it immediately add revenue upon final closing of the deal, but it will also add infrastructure, expertise and a handful of well-regarded brands to our brand lineup. Brian Martin and his team at Emerald City Cultivation and Dabco have done incredible work and built a strong and highly respected company. We are excited to add the BCCTG team to our Washington operation and fill critical open positions with market leading expertise. Final terms will be released upon closing, projected for the end of November 2022.”

Emerald City Cultivation and Dabco are brands known for high quality concentrates product (dab and vape) and with over 40,000 followers have established a well-deserved fanbase. (IG: https://www.instagram.com/dabco/, https://www.instagram.com/emeraldcitycultivation/, https://www.instagram.com/dabs4less/).

“Combining forces with Artizen and offering a complete and potent product lineup to Washington retailers has been a vision of mine for some time now,” said Brian Martin, Founder and President of BCCTG and Emerald City Cultivation. “Being able to do this, take care of our investors who have been with us from the beginning of this venture, and join the Artizen team is a wonderful opportunity. Artizen is one of the original Washington State cannabis brands and our combined lineup will allow retailers to offer a variety of products across multiple price points, all from a single trusted partner. Combining our assets and experience will also allow us to enter markets outside of Washington and take our vision and duplicate it in other markets. Look out for more announcements regarding new products over the next few weeks and months.”

[Robertscott]

$PVSP Artizen On Instagram:

https://www.instagram.com/reel/CVRjKSOBw4c/

[Robertscott]

$GOGY Golden Grail Technology (OTC: GOGY) announces increase in direct-to-consumer sales for KOZ Water
 $GCT $SIGA $STBX $GOVX $GOGY $LTNC $NICH $LFAP $AZFL

[Robertscott]

$GOGY STAY UDATED HERE News and Headlines https://www.barchart.com/stocks/quotes/GOGY/news

[Snowie]

$AGYP on watch! >> Allied Energy Enters into Joint Venture Agreement with Walker Green Tech

WalkerGreen Tech CEO, Ladda C. Walker, commented on the news: "By entering into the joint-venture agreement with Allied Energy and River Energy Group, LLC, WGT sees the new way to not only lower emissions but to monetize stranded natural gas and perfect solutions for the cryptocurrency industry."

https://www.marketwatch.com/press-release/allied-energy-enters-into-joint-venture-agreement-with-walker-green-tech-2022-10-19?mod=mw_quote_news_seemore

[Snowie]

$APSI @ .31! >> Angola’s Tradition Transportation Group to be acquired
https://www.insideindianabusiness.com/articles/angolas-tradition-transportation-group-to-be-acquired

https://t.co/MzRM9DUPTt $APSI

— APSI - Aqua Power Systems Inc (@inc_apsi) October 14, 2022

[Robertscott]

$HLRTF By taking a leadership position in the energy transition, Hillcrest Energy Technologies is focused on creating value for our shareholders by balancing short-term revenue maximization with long-term business disruption risk and expansion of the Company’s reach into global markets. https://investorbrandmedia.com/hlrtf-a-clean-technology-company-developing-transformative-power-conversion-technologies-and-control-system-solutions-for-next-generation-electrical-systems/

[Robertscott]

$PVSP 24 Months plan detail

Rename Pervasip Corp to Artizen Corporation by year end 2022 to better reflect the new focus of the company

Change the OTC ticker symbol

Re-brand all Pervasip/Artizen assets

Continue to rationalize the business through Q1 2023 with a focus on operating margins, shedding underperforming assets, consolidating operations and focus in-house talent on higher margin operations and product lines

Acquire concentrates assets by end of 2022, launching into the highly lucrative concentrates business

Expand flower and concentrates offerings within our brands as well as adding new brands for certain product offerings and price points through Q1 2023

Complete the audit and begin the OTC QB application process during Q2 2023

Launch Artizen Wellness Q2 2023

Enter the edibles market in Q2 2023 via acquisition and partnerships

Artizen becomes an MSO with cultivation and retail assets in 1 – 2 additional states during 2nd half of 2024, beginning its state expansion in Q1 2023, initially through brand licensing opportunities and strategic partnerships, and eventually via acquisitions and mergers during Q3 and Q4 2024

Close first brand licensing agreement by end of Q4 2022

Close one brand licensing deal every quarter thereafter

Financial Outlook Q3 2022 through Q4 2023

Reach $2.0 million in monthly revenue by end of Q1 2023

Reach $2.5 million or $30 million in annualized revenue by end of Q4 2023 with 30% in adjusted EBIDTA

Reach $3.0 million or $36 million in annualized revenues by end of Q2 2024 with 35% in adjusted EBIDTA

Reach $50 million in annualized revenue with 35% in adjusted EBIDTA

[Robertscott]

$HLRTF IS SOLVING MAJOR CHALLENGES FACED
BY TODAY’S EV OEM’S